Analytical Lens: Exploring Tecogen Inc (TGEN)’s Financial Story Through Ratios

Ulysses Smith

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

The closing price of Tecogen Inc (AMEX: TGEN) was $8.16 for the day, down -7.48% from the previous closing price of $8.82. In other words, the price has decreased by -$7.48 from its previous closing price. On the day, 0.72 million shares were traded. TGEN stock price reached its highest trading level at $8.99 during the session, while it also had its lowest trading level at $7.94.

Ratios:

Our analysis of TGEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.67 and its Current Ratio is at 1.36. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.33.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Roth Capital on August 18, 2025, initiated with a Buy rating and assigned the stock a target price of $15.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 03 ’25 when Lafaille Stephen bought 400 shares for $2.50 per share. The transaction valued at 1,000 led to the insider holds 400 shares of the business.

Lafaille Stephen sold 25,000 shares of TGEN for $149,500 on Jun 06 ’25. The VP of Business Development now owns 400 shares after completing the transaction at $5.98 per share. On Jun 04 ’25, another insider, Lafaille Stephen, who serves as the VP of Business Development of the company, sold 15,000 shares for $5.00 each. As a result, the insider received 75,000 and left with 400 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGEN now has a Market Capitalization of 242276912 and an Enterprise Value of 244172416. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.22 while its Price-to-Book (P/B) ratio in mrq is 22.93. Its current Enterprise Value per Revenue stands at 9.292 whereas that against EBITDA is -77.668.

Stock Price History:

The Beta on a monthly basis for TGEN is 1.23, which has changed by 8.3136215 over the last 52 weeks, in comparison to a change of 0.13355756 over the same period for the S&P500. Over the past 52 weeks, TGEN has reached a high of $12.07, while it has fallen to a 52-week low of $0.84. The 50-Day Moving Average of the stock is -3.40%, while the 200-Day Moving Average is calculated to be 45.52%.

Shares Statistics:

TGEN traded an average of 855.80K shares per day over the past three months and 655290 shares per day over the past ten days. A total of 25.57M shares are outstanding, with a floating share count of 15.73M. Insiders hold about 47.01% of the company’s shares, while institutions hold 15.07% stake in the company. Shares short for TGEN as of 1760486400 were 1220298 with a Short Ratio of 1.43, compared to 1757894400 on 1197465. Therefore, it implies a Short% of Shares Outstanding of 1220298 and a Short% of Float of 5.7700000000000005.

Earnings Estimates

. The current rating of Tecogen Inc (TGEN) reflects the combined expertise of 1 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.

Analysts are recommending an EPS of between -$0.17 and -$0.17 for the fiscal current year, implying an average EPS of -$0.17. EPS for the following year is -$0.05, with 1 analysts recommending between -$0.05 and -$0.05.

Revenue Estimates

For the next quarter, 1 analysts are estimating revenue of $7.27M. There is a high estimate of $7.27M for the next quarter, whereas the lowest estimate is $7.27M.

Based on 1 analysts’ estimates, the company’s revenue will be $42.78M in the next fiscal year. The high estimate is $42.78M and the low estimate is $42.78M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.